April 28, 2025 Kigali, Rwanda and San Francisco, USA

Bio Usawa is proud to celebrate Mr. Tirumal Rao, Global Business and Quality Advisor, for delivering an invited presentation at the 2nd International Conference of Reproductive Science and Medicine, Embryology and Andrology. The conference, organized by Department of Physiology at the University of Malaya, showcased key contemporary topics relating to streamlining and accelerating R & D for essential, innovative medicines including monoclonal antibodies and vaccines.

Topics such as these are wholly aligned with Bio Usawa’s commitment to advancing health equity, achieving biotechnology sovereignty, and addressing critical gaps in severe and infectious disease treatments in Africa.

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.